Inicio>>Signaling Pathways>> Immunology/Inflammation>> TLR>>Polyinosinic-polycytidylic acid sodium

Polyinosinic-polycytidylic acid sodium

Catalog No.GC60297

El Ácido poliinosÍnico-policitidÍlico sÓdico (poli(I:C) sÓdico) es un anÁlogo sintético del ARN bicatenario y un agonista del receptor tipo toll 3 (TLR3) y los receptores similares al gen I inducible por Ácido retinoico (RIG-I) ( RIG-I y MDA5).

Products are for research use only. Not for human use. We do not sell to patients.

Polyinosinic-polycytidylic acid sodium Chemical Structure

Cas No.: 42424-50-0

Tamaño Precio Disponibilidad Cantidad
10mg
173,00 $
Disponible
50mg
690,00 $
Disponible

Tel:(909) 407-4943 Email: sales@glpbio.com


Reseñas de cliente

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Protocol Chemical Properties Product Documents Related Products

Polyinosinic-polycytidylic acid sodium(Poly I:C) is a synthetic dsRNA that can imitate a viral infection and elicit host immune responses by triggering specific pattern-recognition receptors (PRRs) such as toll-like receptor 3(TLR3) and retinoic acid inducible gene I(RIG-I)-like receptors, including RIG-I and melanoma differentiation-associated gene 5. Poly I:C can be used as a vaccine adjuvant for cancer immunotherapy[1-3].

poly(I:C)(20 µg in 0.2 mL of cell suspension)-electroporated AML cells potently activate DC and NK cell functions and stimulate NK-DC cross-talk in terms of tumor cell killing[4]. Activation of the TLR3 signaling pathway in cancer cells through poly I:C(100 µg/ml;72 h) makes Hela cells (human cervical cancer) dose-dependent sensitive to apoptosis induced by the protein synthesis inhibitor cycloheximide (CHX) [5].

Poly I:C(10 µg/g;p.o.) exposure induces severe intestinal injury and inflammation[6]. Pre-treatment with the viral TLR3 agonist poly(I:C) (20/200 µg) modulated innate immune responses and strengthened the resistance of neutropenic mice against E. coli K1 meningoencephalitis[7].The intratumoral synergistic combination of poly(I:C)(25 µg;i.p; six times from day9-day21)+R848 significantly prevented tumor growth and metastasis in lung cancer and fibrosarcoma immunocompetent murine models[8].

References:
[1]. Zhao X, Ai M, et,al. Poly I:C-induced tumor cell apoptosis mediated by pattern-recognition receptors. Cancer Biother Radiopharm. 2012 Nov;27(9):530-4. doi: 10.1089/cbr.2012.1226. Epub 2012 Oct 12. PMID: 23062195.
[2]. Zhao X, Ai M, et,al.Poly I:C-induced tumor cell apoptosis mediated by pattern-recognition receptors. Cancer Biother Radiopharm. 2012 Nov;27(9):530-4. doi: 10.1089/cbr.2012.1226. Epub 2012 Oct 12. PMID: 23062195.
[3]. Kato H, Takeuchi O, et,al.Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature. 2006 May 4;441(7089):101-5. doi: 10.1038/nature04734. Epub 2006 Apr 9. PMID: 16625202.
[4]. Lion E, Anguille S, et,al.Poly(I:C) enhances the susceptibility of leukemic cells to NK cell cytotoxicity and phagocytosis by DC. PLoS One. 2011;6(6):e20952. doi: 10.1371/journal.pone.0020952. Epub 2011 Jun 17. PMID: 21698118; PMCID: PMC3117863.
[5]. Jiang Q, Wei H, et,al.Poly I:C enhances cycloheximide-induced apoptosis of tumor cells through TLR3 pathway. BMC Cancer. 2008 Jan 17;8:12. doi: 10.1186/1471-2407-8-12. PMID: 18199340; PMCID: PMC2242792.
[6]. Ginzel M, Yu Y, et,al.The viral dsRNA analogue poly (I:C) induces necrotizing enterocolitis in neonatal mice. Pediatr Res. 2016 Apr;79(4):596-602. doi: 10.1038/pr.2015.261. Epub 2015 Dec 17. PMID: 26679153.
[7]. Ribes S, Arcilla C, et,al.Pre-treatment with the viral Toll-like receptor 3 agonist poly(I:C) modulates innate immunity and protects neutropenic mice infected intracerebrally with Escherichia coli. J Neuroinflammation. 2020 Jan 17;17(1):24. doi: 10.1186/s12974-020-1700-4. PMID: 31952519; PMCID: PMC6969464.
[8]. Anfray C, Mainini F, et,al.Intratumoral combination therapy with poly(I:C) and resiquimod synergistically triggers tumor-associated macrophages for effective systemic antitumoral immunity. J Immunother Cancer. 2021 Sep;9(9):e002408. doi: 10.1136/jitc-2021-002408. PMID: 34531246; PMCID: PMC8449972.

Reseñas

Review for Polyinosinic-polycytidylic acid sodium

Average Rating: 5 ★★★★★ (Based on Reviews and 14 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Polyinosinic-polycytidylic acid sodium

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.